Perspective Therapeutics, Inc. (CATX)
Perspective Therapeutics, Inc. (CATX) has reported earnings 22 times since May 13, 2021. The stock moves an average of ±5.38% the day after reporting, closing higher 40.9% of the time. Its largest post-earnings gain was +8.7% (Nov 14, 2023) and its largest decline was -26.67% (Sep 28, 2022). The next earnings report is predicted for 2026-11-13 (estimated).
Earnings reactions
How CATX moved on each past earnings report.
Earnings Impact
Total Earnings
22
Avg Abs. Movement
±5.38%
Positive %
40.9%
Negative %
59.1%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 10, 2026 | ☽ POST | +6.02% | open_in_new |
| May 11, 2026 | ☽ POST | -2.32% | open_in_new |
| May 04, 2026 | ☽ POST | -8.78% | open_in_new |
| Mar 16, 2026 | ☽ POST | -5.17% | open_in_new |
Earnings Count
22
Total earnings in dataset
Avg Abs. Movement
±5.38%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260908 | open_in_new SEC.gov |
| 8-K | 20260908 | open_in_new SEC.gov |
| 4 | 20260904 | open_in_new SEC.gov |
| 4 | 20260904 | open_in_new SEC.gov |
| SCHEDULE 13D/A | 20260904 | open_in_new SEC.gov |
| 4 | 20260903 | open_in_new SEC.gov |
| 4 | 20260902 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260813 | open_in_new SEC.gov |
| 10-Q | 20260810 | open_in_new SEC.gov |
| 8-K | 20260810 | open_in_new SEC.gov |
Frequently asked about CATX earnings
When does Perspective Therapeutics, Inc. report earnings next? expand_more
Perspective Therapeutics, Inc. (CATX)'s next earnings date is estimated for 2026-11-13. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does CATX stock move after earnings? expand_more
Over 22 reports, CATX has moved an average of ±5.38% the session after earnings, closing higher 40.9% of the time.
What was CATX's biggest post-earnings move? expand_more
CATX's largest post-earnings gain on record was +8.7% on Nov 14, 2023, and its largest decline was -26.67% on Sep 28, 2022.
Where can I find Perspective Therapeutics, Inc.'s SEC filings? expand_more
All of Perspective Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right